Advertisement

Reactions Weekly

, Volume 1722, Issue 1, pp 308–308 | Cite as

Rituximab

Cholangiohepatitis, intestinal perforation and rectal cancer follwing off-label use: case report
Case report
  • 36 Downloads

Reference

  1. Berntsson SG, et al. Rapidly increasing off-label use of rituximab in multiple sclerosis in Sweden - Outlier or predecessor? Acta Neurologica Scandinavica 138: 327-331, No. 4, Oct 2018. Available from: URL: https://doi.org/10.1111/ane.12963 - Sweden

Copyright information

© Springer Nature Switzerland AG 2018

Personalised recommendations